Skip to main content
Fig. 2 | BMC Complementary Medicine and Therapies

Fig. 2

From: A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects

Fig. 2

Fold-changes of IL17A, IFNγ, TNFα, IL2, IL4, IL6, and IL10 compared with baseline levels in healthy Thai subjects following the administration of daily oral doses of 1000 mg standardized AL extract (n = 20) and placebo (n = 4). Data are presented as median (range) values

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us